Blackbody' Iressa (gefitinib) is a new type of small molecular weight tumor treatment drug. Its mechanism of action is mainly to block conduction by inhibiting autophosphorylation, inhibit the proliferation of tumor cells, and achieve targeted therapy. Clinically, it is mainly used to treat locally advanced or metastatic non-small cell lung cancer that has received chemotherapy in the past. It is especially effective for lung adenocarcinoma. The efficacy for squamous cell carcinoma is lower than that for adenocarcinoma and alveolar carcinoma. However, a large amount of clinical data shows that according to lung cancer The actual situation of the patients: After treatment with Iressa (gefitinib), some patients with lung squamous cell carcinoma and other non-small cell lung cancer still have obvious effects and are well tolerated.
HeiTi' HeiTi' HeiTi' Manufacturer India Pharmaceuticals
HeiTi' HeiTi' Trade name Iressa
HeiTi' HeiTi' Generic name Gefitinib
HeiTi' HeiTi' HeiTi' Iressa, gefitinib tablets
HeiTi'HeiTi'English name,,
HeiTi'HeiTi'Specification*Indian version/bottle
HeiTi'HeiTi'Storage below ℃, stored in the original In the package (just keep it in a cool place indoors)
黑体' 黑体' Validity Year
黑体' 黑体'
News